• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.比较用于构建组织工程血管移植物的人骨髓单核细胞分离方法:新型过滤系统与传统密度离心法。
Tissue Eng Part C Methods. 2011 Oct;17(10):993-8. doi: 10.1089/ten.TEC.2011.0110. Epub 2011 Jul 1.
2
Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.两种用于制备组织工程血管移植物的骨髓单个核细胞分离方法的生物学等效性比较。
Tissue Eng Part C Methods. 2015 Jun;21(6):597-604. doi: 10.1089/ten.TEC.2014.0442. Epub 2014 Dec 29.
3
Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.骨髓单个核细胞接种在纳米纤维血管移植物中的作用。
Tissue Eng Part A. 2018 Jan;24(1-2):135-144. doi: 10.1089/ten.TEA.2017.0044. Epub 2017 Jun 13.
4
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.评估诱导多能干细胞片在组织工程血管移植物构建中的应用。
J Thorac Cardiovasc Surg. 2012 Mar;143(3):696-703. doi: 10.1016/j.jtcvs.2011.06.046. Epub 2012 Jan 12.
5
The Impact of Centrifugal Force on Isolation of Bone Marrow Mononuclear Cells Using Density Gradient Centrifugation.离心力对利用密度梯度离心法分离骨髓单个核细胞的影响。
Aesthetic Plast Surg. 2024 May;48(9):1855-1866. doi: 10.1007/s00266-024-03892-8. Epub 2024 Feb 22.
6
Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.改良型组织工程血管移植物的合理设计:确定最佳细胞剂量和孵育时间。
Regen Med. 2016 Mar;11(2):159-67. doi: 10.2217/rme.15.85. Epub 2016 Feb 29.
7
Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts.用于制备组织工程血管移植物的封闭系统与标准开放技术的比较。
Tissue Eng Part C Methods. 2015 Jan;21(1):88-93. doi: 10.1089/ten.TEC.2014.0160.
8
Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.利用骨髓来源的血管细胞构建自体组织工程静脉导管:细胞采集与接种技术的优化
J Pediatr Surg. 2007 Jan;42(1):198-202. doi: 10.1016/j.jpedsurg.2006.09.054.
9
Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.使用自动化封闭分离系统Sepax分离成人骨髓单个核细胞。
Cytotherapy. 2008;10(2):203-11. doi: 10.1080/14653240701851324.
10
Implantation of inferior vena cava interposition graft in mouse model.在小鼠模型中植入下腔静脉间置移植物。
J Vis Exp. 2014 Jun 4(88):51632. doi: 10.3791/51632.

引用本文的文献

1
Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth.组织工程血管移植物可转化为具有天然功能和生长能力的自体新血管。
Commun Med (Lond). 2022 Jan 10;2:3. doi: 10.1038/s43856-021-00063-7. eCollection 2022.
2
Systematic Review of Tissue-Engineered Vascular Grafts.组织工程血管移植物的系统评价
Front Bioeng Biotechnol. 2021 Nov 3;9:771400. doi: 10.3389/fbioe.2021.771400. eCollection 2021.
3
Enhancing the Surface Properties of a Bioengineered Anterior Cruciate Ligament Matrix for Use with Point-of-Care Stem Cell Therapy.增强生物工程化前交叉韧带基质的表面特性以用于即时护理干细胞治疗。
Engineering (Beijing). 2021 Feb;7(2):153-161. Epub 2020 May 7.
4
Effect of Freshly Isolated Bone Marrow Mononuclear Cells and Cultured Bone Marrow Stromal Cells in Graft Cell Repopulation and Tendon-Bone Healing after Allograft Anterior Cruciate Ligament Reconstruction.新鲜分离的骨髓单核细胞和培养的骨髓基质细胞对同种异体前交叉韧带重建后移植物细胞再定植和腱骨愈合的影响。
Int J Mol Sci. 2021 Mar 10;22(6):2791. doi: 10.3390/ijms22062791.
5
Spontaneous reversal of stenosis in tissue-engineered vascular grafts.组织工程血管移植物狭窄的自发逆转。
Sci Transl Med. 2020 Apr 1;12(537). doi: 10.1126/scitranslmed.aax6919.
6
Factors Influencing Poor Outcomes in Synthetic Tissue-Engineered Tracheal Replacement.影响合成组织工程气管置换不良结局的因素。
Otolaryngol Head Neck Surg. 2019 Sep;161(3):458-467. doi: 10.1177/0194599819844754. Epub 2019 Apr 30.
7
Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart".生物材料与心脏恢复:MCS时代的心脏修复、再生与愈合:“心脏”现状
J Thorac Dis. 2018 Jul;10(Suppl 20):S2346-S2362. doi: 10.21037/jtd.2018.01.85.
8
Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration.干细胞和细胞外囊泡在血管组织再生中的作用的未来展望
Front Cardiovasc Med. 2018 Jul 3;5:86. doi: 10.3389/fcvm.2018.00086. eCollection 2018.
9
COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.比较CPM-RMI试验:近期心肌梗死患者冠状动脉搭桥术中自体骨髓来源的CD133+细胞和单个核细胞心肌内移植:一项II/III期、多中心、安慰剂对照、随机、双盲临床试验。
Cell J. 2018 Jul;20(2):267-277. doi: 10.22074/cellj.2018.5197. Epub 2018 Mar 18.
10
Toward a patient-specific tissue engineered vascular graft.迈向个性化组织工程血管移植物。
J Tissue Eng. 2018 Mar 16;9:2041731418764709. doi: 10.1177/2041731418764709. eCollection 2018 Jan-Dec.

本文引用的文献

1
Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations.菲可-泛影葡胺与淋巴细胞分离液:两种用于治疗性骨髓单个核细胞制备的密度梯度介质的比较研究
Regen Med. 2009 Sep;4(5):689-96. doi: 10.2217/rme.09.44.
2
Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.组织工程血管移植物植入幼年动物模型时显示出生长和发育的迹象。
Ann Surg. 2008 Sep;248(3):370-7. doi: 10.1097/SLA.0b013e318184dcbd.
3
Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.用于小鼠模型功能性血管组织工程的小直径可生物降解支架
Biomaterials. 2008 Apr;29(10):1454-63. doi: 10.1016/j.biomaterials.2007.11.041. Epub 2007 Dec 27.
4
Evaluation of tissue-engineered vascular autografts.组织工程化血管自体移植物的评估
Tissue Eng. 2006 Nov;12(11):3075-83. doi: 10.1089/ten.2006.12.3075.
5
Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.细胞分离程序很重要:急性心肌梗死患者细胞治疗中使用的不同骨髓单个核细胞分离方案的比较
Eur Heart J. 2007 Mar;28(6):766-72. doi: 10.1093/eurheartj/ehl509. Epub 2007 Feb 13.
6
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.急性心肌梗死中的冠状动脉内骨髓源性祖细胞
N Engl J Med. 2006 Sep 21;355(12):1210-21. doi: 10.1056/NEJMoa060186.
7
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.急性心肌梗死时冠状动脉内注射单个核骨髓细胞
N Engl J Med. 2006 Sep 21;355(12):1199-209. doi: 10.1056/NEJMoa055706.
8
Development of a model system for preliminary evaluation of tissue-engineered vascular conduits.用于组织工程血管移植物初步评估的模型系统的开发。
J Pediatr Surg. 2006 Apr;41(4):787-91. doi: 10.1016/j.jpedsurg.2006.02.019.
9
Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy.作为细胞治疗中潜在可用的CD 34+祖细胞来源的全血白细胞去除滤器。
Transfusion. 2006 Jan;46(1):118-25. doi: 10.1111/j.1537-2995.2005.00677.x.
10
Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.过滤后的血沉棕黄层(FBC):从白细胞去除过滤器中回收的外周血白细胞来源。
J Immunol Methods. 2005 Dec 20;307(1-2):150-66. doi: 10.1016/j.jim.2005.10.004. Epub 2005 Nov 17.

比较用于构建组织工程血管移植物的人骨髓单核细胞分离方法:新型过滤系统与传统密度离心法。

Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.

机构信息

Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

出版信息

Tissue Eng Part C Methods. 2011 Oct;17(10):993-8. doi: 10.1089/ten.TEC.2011.0110. Epub 2011 Jul 1.

DOI:10.1089/ten.TEC.2011.0110
PMID:21609305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182675/
Abstract

INTRODUCTION

We created the first tissue-engineered vascular graft (TEVG) to be successfully used in humans. The TEVG is made by seeding autologous bone marrow-derived mononuclear cells (BM-MNCs) onto a biodegradable tubular scaffold fabricated from polyglycolic-acid mesh coated with a 50:50 copolymer of poly-L-lactide and-ɛ-caprolactone. In the initial clinical study, the BM-MNCs were isolated using a Ficoll density centrifugation method. Use of this cell isolation technique is problematic in that it is performed using an open system and therefore is susceptible to contamination. As a first step toward creating a closed system for assembling a TEVG, we evaluated the use of a filter-based method for isolating BM-MNCs and compared it to density centrifugation in Ficoll.

METHODS

BM-MNCs were isolated from human BM using density centrifugation in Ficoll or a filter-based method. BM-MNCs were seeded onto biodegradable tubular scaffold and incubated for 24 h before implantation. The TEVG were implanted as inferior vena cava interposition grafts in SCID/bg mice (n=24) using microsurgical technique. Grafts were followed with ultrasonography and computed tomography-angiography. Ten weeks after implantation the TEVG were explanted and examined using histology and immunohistochemistry.

RESULTS

Both methods isolated similar number of cells (Ficoll: 8.5±6.6×10(6)/mL, Filter: 6.6±3.5×10(6)/mL; p=0.686) with similar viability as assayed using fluorescence-activated cell sorting (FACS) (Ficoll: 97.0%±1.5%, Filter: 95.9%±3.0%; p=0.339). FACS analysis demonstrated that the fraction of lymphocytes and monocytes to total cells was lower in the filter group (CD4 in Ficoll: 8.9%±1.1%, CD4 in Filter: 3.5%±0.8%; p=0.002, CD8 in Ficoll: 9.4%±2.1%, CD8 in Filter: 3.9%±1.4%; p=0.021, Monocyte in Ficoll: 6.9%±1.0%, Monocyte in Filter: 2.7%±1.0%; p=0.008), consistent with granulocyte contamination (Ficoll: 46.6±2.7×10(6)/mL, Filter: 58.1±5.2×10(6)/mL; p<0.001). The ratio of stem cells to BM-MNCs was comparable between groups. There were no statistically significant differences with regard to TEVG patency and morphology between groups. Both methods of cell isolation produced neovessels with similar histology.

CONCLUSION

Filter-based BM-MNC isolation is comparable to BM-MNC isolation using density centrifugation in Ficoll for TEVG assembly. The filter-based cell isolation technique has the added advantage of the potential to create a closed disposable system.

摘要

简介

我们成功地将首个组织工程血管移植物(TEVG)应用于人体。该 TEVG 是通过将自体骨髓来源的单核细胞(BM-MNC)接种到由聚乙二醇酸网制成的可生物降解的管状支架上制成的,该支架涂有聚 L-乳酸和-ε-己内酯的 50:50 共聚物。在最初的临床研究中,BM-MNC 是使用菲可密度离心法分离的。使用这种细胞分离技术存在问题,因为它是在开放系统中进行的,因此容易受到污染。作为创建用于组装 TEVG 的封闭系统的第一步,我们评估了使用基于过滤器的方法分离 BM-MNC 的方法,并将其与菲可密度离心法进行了比较。

方法

使用菲可密度离心法或基于过滤器的方法从人骨髓中分离 BM-MNC。将 BM-MNC 接种到可生物降解的管状支架上,并在植入前孵育 24 小时。使用显微外科技术将 TEVG 作为下腔静脉间置移植物植入 SCID/bg 小鼠(n=24)中。使用超声和计算机断层血管造影术对移植物进行随访。植入 10 周后,取出 TEVG 并进行组织学和免疫组织化学检查。

结果

两种方法分离的细胞数量相似(菲可密度离心法:8.5±6.6×10(6)/mL,过滤器:6.6±3.5×10(6)/mL;p=0.686),使用荧光激活细胞分选(FACS)测定的存活率也相似(菲可密度离心法:97.0%±1.5%,过滤器:95.9%±3.0%;p=0.339)。FACS 分析表明,过滤器组的淋巴细胞和单核细胞与总细胞的比例较低(菲可密度离心法:CD4 为 8.9%±1.1%,CD4 为 3.5%±0.8%;p=0.002,CD8 为 9.4%±2.1%,CD8 为 3.9%±1.4%;p=0.021,单核细胞为 6.9%±1.0%,单核细胞为 2.7%±1.0%;p=0.008),与粒细胞污染一致(菲可密度离心法:46.6±2.7×10(6)/mL,过滤器:58.1±5.2×10(6)/mL;p<0.001)。两组之间 BM-MNC 中干细胞的比例无统计学差异。两组之间 TEVG 通畅率和形态无统计学差异。两种细胞分离方法均产生具有相似组织学的新生血管。

结论

基于过滤器的 BM-MNC 分离与使用菲可密度离心法分离 BM-MNC 用于 TEVG 组装相当。基于过滤器的细胞分离技术具有潜在的优势,可以创建封闭的一次性系统。